Results 241 to 250 of about 40,261 (314)
A case of adenoid cystic carcinoma of the larynx: Diagnostic challenges, surgical management, and long-term surveillance. [PDF]
Lachkar A +3 more
europepmc +1 more source
ABSTRACT Papillary carcinoma arising in a thyroglossal duct cyst is rare and often indistinguishable from benign disease. We report a male patient with progressive cyst changes leading to diagnosis and successful Sistrunk‐based management, highlighting the need for close, appropriate imaging and individualized treatment in midline neck masses.
Nasim Abukaresh +6 more
wiley +1 more source
Machine learning: predicting lymph node metastasis around the entrance point to the recurrent laryngeal nerve in cN0 papillary thyroid carcinoma. [PDF]
Peng J +5 more
europepmc +1 more source
ABSTRACT Background Oropharyngeal squamous cell carcinoma (OPSCC) accounts for a substantial proportion of head and neck cancers, with a rising incidence largely driven by human papillomavirus (HPV) infection. Despite advances in multimodal treatment, disease recurrence remains common and limits long‐term survival, highlighting the need for reliable ...
Yunxia Chen +7 more
wiley +1 more source
Primary intestinal-type adenocarcinoma of the larynx: A case report and literature review. [PDF]
Ma H, Li X, Zhao D, Lou Z.
europepmc +1 more source
What Is Your Diagnosis? Submandibular Mass in a Dog
Veterinary Clinical Pathology, EarlyView.
Whitney K. Chandler +3 more
wiley +1 more source
ABSTRACT Background Synchronous cancers, defined as malignancies diagnosed concurrently or within 2 months of each other, are rare, with an incidence of 1%–6%. Environmental factors such as tobacco smoking play a significant role in their development. Patients with head and neck squamous cell carcinoma (SCC) are at increased risk of second malignancies,
Aleksandra Nasiek +6 more
wiley +1 more source
Circulating miR-99a-5p and miR-1246 as Diagnostic and Stage-Associated Biomarkers in Laryngeal Squamous Cell Carcinoma. [PDF]
Hut AR +8 more
europepmc +1 more source
ABSTRACT Background University of Michigan Cancer Center (UMCC) protocol 9520 treated stage III/IV locally advanced squamous cell carcinoma of the larynx (LASCCL) with cisplatin and 5‐fluorouracil to select for definitive therapy based on response.
Zachary Risch +19 more
wiley +1 more source

